These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38004497)

  • 21. Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine.
    Schwartz MD; Palmerston JB; Lee DL; Hoener MC; Kilduff TS
    Front Pharmacol; 2018; 9():35. PubMed ID: 29456505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological evaluation and
    Wang Y; Liu Z; Lu J; Wang W; Wang L; Yang Y; Wang H; Ye L; Zhang J; Tian J
    Front Pharmacol; 2023; 14():1161964. PubMed ID: 37153799
    [No Abstract]   [Full Text] [Related]  

  • 23. A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2009 Jul; 330(1):316-25. PubMed ID: 19364908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
    Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
    Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT
    Saarinen M; Mantas I; Flais I; Ågren R; Sahlholm K; Millan MJ; Svenningsson P
    Neuropsychopharmacology; 2022 Dec; 47(13):2319-2329. PubMed ID: 36100653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
    J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trace amine associated receptor 1: predicted effects of single nucleotide variants on structure-function in geographically diverse populations.
    Shajan B; Marri S; Bastiampillai T; Gregory KJ; Hellyer SD; Nair PC
    Hum Genomics; 2024 Jun; 18(1):61. PubMed ID: 38863077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
    Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
    Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
    Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
    PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
    Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.
    Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trace amine-associated receptor 1 is a modulator of the dopamine transporter.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2007 Apr; 321(1):128-36. PubMed ID: 17234899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.
    Shang P; Rong N; Jiang JJ; Cheng J; Zhang MH; Kang D; Qi L; Guo L; Yang GM; Liu Q; Zhou Z; Li XB; Zhu KK; Meng QB; Han X; Yan W; Kong Y; Yang L; Wang X; Lei D; Feng X; Liu X; Yu X; Wang Y; Li Q; Shao ZH; Yang F; Sun JP
    Cell; 2023 Nov; 186(24):5347-5362.e24. PubMed ID: 37963465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.
    Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME
    J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand recognition and G-protein coupling of trace amine receptor TAAR1.
    Xu Z; Guo L; Yu J; Shen S; Wu C; Zhang W; Zhao C; Deng Y; Tian X; Feng Y; Hou H; Su L; Wang H; Guo S; Wang H; Wang K; Chen P; Zhao J; Zhang X; Yong X; Cheng L; Liu L; Yang S; Yang F; Wang X; Yu X; Xu Y; Sun JP; Yan W; Shao Z
    Nature; 2023 Dec; 624(7992):672-681. PubMed ID: 37935376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
    Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
    Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.
    Heffernan MLR; Herman LW; Brown S; Jones PG; Shao L; Hewitt MC; Campbell JE; Dedic N; Hopkins SC; Koblan KS; Xie L
    ACS Med Chem Lett; 2022 Jan; 13(1):92-98. PubMed ID: 35047111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
    Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
    Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAAR1-dependent effects of apomorphine in mice.
    Sukhanov I; Espinoza S; Yakovlev DS; Hoener MC; Sotnikova TD; Gainetdinov RR
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1683-93. PubMed ID: 24925023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.